What Drugs Make Your Eyes Sensitive to Light?

Dozens of widely prescribed medications can make your eyes uncomfortably sensitive to light, a symptom doctors call photophobia. The culprits span nearly every pharmacy shelf: acne treatments, antidepressants, heart medications, antibiotics, erectile-dysfunction pills, allergy drugs, and more. They do it through surprisingly different routes, from forcing the pupil open too wide to drying out the eye’s surface to disrupting the chemistry of the retina itself. Understanding which drugs cause the problem, and how, helps you figure out whether a new sensitivity to sunlight or glare is something to mention to your prescriber or ride out on your own.

Drugs That Force the Pupil Open

The most straightforward way a drug makes light painful is by dilating the pupil. A wider pupil lets more light flood onto the retina than the eye was designed to handle at that moment. The classic example is atropine, a medication used to treat certain eye conditions and slow the progression of nearsightedness in children. Even very low concentrations of atropine eye drops cause meaningful dilation: a study testing three low-dose formulations found that the highest concentration (0.05%) pushed the pupil open to about 7.4 mm in dim light, and the pupil was still significantly enlarged a full day later. Participants on that dose reported the most light sensitivity and glare, while those on the lowest dose (0.01%) had far fewer complaints.¹ This dose-dependent pattern is useful to know: the more a drug widens the pupil, the worse the light sensitivity tends to be.

Atropine works by blocking acetylcholine at the muscle that constricts the pupil, and many other drugs share some version of that anticholinergic activity. Tricyclic antidepressants (TCAs) like amitriptyline and nortriptyline are well-known for this. They can produce mydriasis, the medical term for an abnormally dilated pupil, which brings blurred vision and photosensitivity along with it. The visual side effects are typically mild and temporary, but in people who do not develop tolerance to the drug’s effect on the eye’s smooth muscle, the symptoms can persist.²

Selective serotonin reuptake inhibitors (SSRIs) like fluoxetine, sertraline, and escitalopram can also dilate the pupil, though through a slightly different cocktail of actions: serotonin receptor activity, noradrenergic effects, and some residual anticholinergic punch. The same case-report review linking SSRIs to mydriasis noted that the combination of a wider pupil and bright sunlight contributed to retinal damage in at least one patient with major depression.² That is an extreme outcome, but it underscores why any new light sensitivity while on a psychotropic medication deserves a conversation with your doctor.

Drugs That Alter the Cornea

The cornea is the clear dome at the front of the eye. It does most of the focusing and sits right in the path of incoming light, so when a drug deposits material inside it or roughens its surface, light scatters instead of passing through cleanly. The result is glare, halos around lights, and a vague sense that everything is too bright.

Amiodarone, a potent heart-rhythm drug, is one of the most common offenders. Nearly all patients taking it at standard doses develop a distinctive pattern of corneal deposits called vortex keratopathy, with golden-brown whorls visible on an eye exam. A case report described a 76-year-old man who complained of halos in both eyes because of these deposits.³ The deposits themselves do not usually destroy vision, but they scatter enough light to make driving at night or facing oncoming headlights noticeably unpleasant. One review noted that roughly 98% of patients on standard amiodarone doses develop these epithelial changes, and that photophobia and halos are among the reported symptoms.⁴

Antimalarial drugs share a similar trick. Chloroquine and hydroxychloroquine, which are widely used for lupus and rheumatoid arthritis, can cause epithelial corneal deposits within weeks to months of starting treatment. A related antimalarial, tafenoquine, produces vortex keratopathy in about 93% of users.⁴ These deposits can cause blurred vision and halos, though many people remain asymptomatic and only learn about them during a routine eye exam. Hydroxychloroquine is prescribed to millions of people worldwide, so the eye-related monitoring guidelines for this drug exist for good reason.

Drugs That Interfere with the Retina

Some medications skip the front of the eye entirely and disrupt the retina, the light-sensitive tissue lining the back of the eye. When the retina’s chemistry is thrown off, you may perceive light as painfully bright, see colored halos, or notice a bluish or yellowish tint to everything.

Sildenafil (Viagra) and related erectile-dysfunction drugs are the best-known examples. They work by blocking an enzyme called PDE5, which relaxes blood vessels. The trouble is that they also weakly inhibit a closely related enzyme, PDE6, found exclusively in the rod and cone cells of the retina. That cross-reactivity causes transient visual disturbances including changes in color perception, blurred vision, and photophobia.⁵ Lab testing has shown that some PDE5-targeting drugs are surprisingly potent inhibitors of retinal PDE6 as well, with vardenafil (Levitra) being the strongest PDE6 inhibitor in that class.⁶ For most users, the visual symptoms are brief and mild, appearing within an hour or two of taking the pill and fading as the drug clears the body. But anyone who experiences persistent visual changes should seek an eye exam.

Digoxin, a heart medication derived from the foxglove plant, can produce more dramatic retinal effects. At toxic levels, it inhibits an enzyme in retinal cells, altering their electrical properties and producing a constellation of visual symptoms: photophobia, yellow-tinted vision (xanthopsia), green-tinted vision, flashing lights, and even visual hallucinations.⁷ One case report described a patient who developed “snowy” and blurry vision, photosensitivity, color-vision changes, and worsening hallucinations over two to three weeks of digoxin toxicity.⁸ Because digoxin has a narrow window between an effective dose and a toxic one, visual symptoms are sometimes the first sign that blood levels have crept too high.

Drugs That Dry Out the Eye Surface

A thin, stable tear film is more important to comfortable vision than most people realize. Tears keep the cornea smooth and well-lubricated; when that moisture layer thins or breaks up, the corneal surface becomes irregular. Light hitting an irregular surface scatters, producing glare, stinging, and sensitivity to bright environments. Several drug classes can sabotage the tear film.

Isotretinoin (Accutane and its generics), the powerful acne medication, is notorious for drying out the eyes. It works partly by shrinking the sebaceous glands, including the meibomian glands in the eyelids that produce the oily layer of the tear film. Research has confirmed that isotretinoin therapy leads to measurable changes in meibomian gland structure and function, increasing complaints of dry, irritated, light-sensitive eyes.⁹ Clinical reports describe patients developing dry eye syndrome after only a few months of treatment, with the meibomian gland dysfunction as the driving factor.¹⁰ The good news is that the changes appear to be reversible after stopping the drug, though recovery can take weeks to months.

Over-the-counter antihistamines are another common cause. First-generation antihistamines like diphenhydramine (Benadryl) have anticholinergic effects that reduce tear production. A controlled study found that a single dose of diphenhydramine reduced tear volume by a statistically significant amount compared to both a placebo and a newer, second-generation antihistamine like loratadine.¹¹ If you take diphenhydramine regularly for allergies or sleep and notice your eyes feeling gritty and light-bothered, the antihistamine itself may be contributing. Second-generation options like loratadine or cetirizine tend to cause less tear-film disruption.

Antibiotics and Anti-Inflammatory Drugs

Tetracycline-class antibiotics, especially doxycycline, are photosensitizers. They absorb ultraviolet light and trigger chemical reactions in exposed tissues, primarily the skin but also the eyes and surrounding structures. In a large study of patients treated with doxycycline for Lyme disease, about 2% reported photosensitivity reactions, with rates climbing to roughly 3% in those who took the drug for 15 days. Women were affected more often than men. Most of the patients who developed reactions had not followed the advice to avoid sun exposure.¹² While that study focused on skin reactions, the underlying photosensitizing mechanism affects the eyelids and ocular surface too, and many doxycycline users report that bright light feels harsher on their eyes during treatment.

Nonsteroidal anti-inflammatory drugs (NSAIDs) like ketoprofen, as well as several cardiovascular medications including hydrochlorothiazide (a common blood-pressure diuretic), atorvastatin, and simvastatin, are also recognized photosensitizers. A survey of elderly patients found that drugs capable of causing phototoxic or photoallergic reactions made up more than a fifth of all medications the participants were taking, and most of those patients were on three to five such drugs simultaneously.¹³ The photosensitizing mechanism involves the drug molecule absorbing UV energy and triggering oxidative stress and inflammation in exposed tissue, leading to symptoms like redness, burning, and swelling on sun-exposed areas including the eyelids and conjunctiva.¹⁴

Chemotherapy and Other Specialty Drugs

Cancer treatments can affect the eyes in a range of ways. Systemic 5-fluorouracil (5-FU), a mainstay chemotherapy agent, commonly causes excessive tearing by narrowing the tear-drainage ducts, a problem that often resolves once the drug is stopped.¹⁵ While tearing is the opposite of dry eye, the resulting overflow and irritation of the ocular surface can still make the eyes more reactive to light. Other chemotherapy agents have been associated with corneal deposits, retinal changes, or inflammation that compounds light sensitivity, though the specifics vary widely by drug and dose.

Topiramate, an anti-seizure medication also prescribed for migraine prevention, has been linked to several ocular side effects including acute-onset nearsightedness and elevated eye pressure resembling glaucoma. Case reports have documented visual field defects in patients on topiramate for more than six months at moderate doses.¹⁶ The sudden shift in focusing ability, combined with fluid accumulation within the eye, can produce glare and difficulty tolerating bright light. The onset is sometimes dramatic enough that patients present to emergency departments, worried they are losing their vision.

Why the Same Drug Bothers Some People More Than Others

Individual variation in drug-induced light sensitivity is enormous. One person on a low dose of an SSRI barely notices any visual change, while another on the same medication squints through every sunny afternoon. Several factors influence this spread.

Age is one of the biggest. Older adults are more likely to be on multiple photosensitizing medications at once. The elderly survey mentioned earlier found that most participants were simultaneously taking three to five drugs with phototoxic potential.¹³ On top of that, aging naturally reduces tear production, thins the cornea slightly, and slows pupil reflexes, so the eyes are already more vulnerable to the effects drugs can pile on. Iris color matters too: lighter-colored irises let more light through the iris tissue itself, so blue- and green-eyed people often notice photosensitivity more acutely than those with darker irises.

Dose and duration play obvious roles. The atropine study showed a clear dose-response relationship, with higher concentrations producing more dilation and more light-sensitivity complaints.¹ The doxycycline study showed a similar pattern: longer courses meant more photosensitivity reactions.¹² And drug interactions can amplify the problem. Taking a medication that dries the eyes together with one that dilates the pupil creates a double hit that neither drug alone might produce.

When Light Sensitivity Is a Warning Sign

Most drug-related photophobia is annoying rather than dangerous. It resolves when the medication is stopped or the dose is lowered, and sunglasses can manage it in the meantime. But certain patterns warrant urgent attention.

Sudden onset of severe light sensitivity with eye pain or redness can signal acute angle-closure glaucoma, a known risk with drugs that dilate the pupil, including topiramate and anticholinergic medications. This is a medical emergency. A rapid change in color vision while on digoxin points to possible toxicity and needs same-day blood-level testing. Persistent visual disturbances after taking sildenafil or a related drug, especially if they last more than 24 hours, deserve an ophthalmology evaluation to rule out damage to the retinal cells.

If you suspect a medication is making your eyes light-sensitive, documenting when the symptom started relative to when you began the drug (or changed the dose) gives your doctor the most useful information. Many of these effects are well-characterized and can be managed by switching to an alternative medication, adjusting the dose, or adding supportive measures like preservative-free artificial tears for dry-eye-related photophobia.

How Light Sensitivity Travels Through the Nervous System

The discomfort you feel from bright light is not entirely an “eye” phenomenon. The trigeminal nerve, which supplies sensation to the face and eyes, plays a central role. Research has shown that bright light can directly increase trigeminal nerve activity, boosting the blink reflex and the rate of spontaneous blinking even when the central visual pathways are not involved.¹⁷ This means that anything irritating the eye surface, whether it is drug-induced dryness, corneal deposits, or inflammation, can lower the threshold at which light triggers pain through this nerve. It also explains why photophobia feels like more than just visual overload: it can come with a headache-like ache behind the eye, a reflexive urge to squint, and even nausea in severe cases.

This trigeminal pathway helps explain a pattern that puzzles many patients: even after the drug-induced pupil dilation or corneal change has partially resolved, lingering sensitivity to light can persist for days or weeks. Once the trigeminal system has been sensitized, it takes time for that nerve circuit to calm back down, much the way a sunburn stays tender after the initial redness fades. Recognizing this lag can keep you from assuming a medication change has not worked when in reality the eye just needs more recovery time.